Published in Cytometry on December 01, 1994
Genetic linkage of pfmdr1 with food vacuolar solute import in Plasmodium falciparum. EMBO J (2006) 1.58
Multidrug resistance transporters in the olfactory receptor neurons of Xenopus laevis tadpoles. J Physiol (2003) 1.02
Monitoring intracellular pH changes in response to osmotic stress and membrane transport activity using 5-chloromethylfluorescein. AAPS PharmSci (2002) 0.87
Cytosolic calcium measurements in renal epithelial cells by flow cytometry. J Vis Exp (2014) 0.76
Immortalisation of a human diploid fibroblast cell strain: a DT-diaphorase paradox. Br J Cancer Suppl (1996) 0.75
Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem (1983) 9.40
Principles and applications of ultrasound backscatter microscopy. IEEE Trans Ultrason Ferroelectr Freq Control (1993) 2.98
An in vitro assay to measure the viability of KHT tumor cells not previously exposed to culture conditions. Radiat Res (1974) 2.62
Clinical and biological significance of aneuploidy in human tumours. J Clin Pathol (1984) 2.39
Increased cell killing by metronidazole and nitrofurazone of hypoxic compared to aerobic mammalian cells. Cancer Res (1976) 2.26
In vivo testing of hypoxic radiosensitizers using the KHT murine tumour assayed by the lung-colony technique. Br J Radiol (1975) 1.86
Application of DNA flow cytometry to paraffin-embedded archival material for the study of aneuploidy and its clinical significance. Cytometry (1985) 1.78
Guidelines for implementation of clinical DNA cytometry. International Society for Analytical Cytology. Cytometry (1993) 1.77
Inhibition of phosphatidylinositide 3-kinase enhances gemcitabine-induced apoptosis in human pancreatic cancer cells. Cancer Res (2000) 1.69
Influence of cellular DNA content on survival in advanced ovarian cancer. Cancer Res (1984) 1.58
Association of involvement in psychological self-regulation with longer survival in patients with metastatic cancer: an exploratory study. Adv Mind Body Med (2000) 1.48
Activity of a novel, dual PI3-kinase/mTor inhibitor NVP-BEZ235 against primary human pancreatic cancers grown as orthotopic xenografts. Br J Cancer (2009) 1.47
Evidence for dark-reactivation of ultraviolet light damage in mouse L cells. Radiat Res (1967) 1.47
Wortmannin inhibits pkb/akt phosphorylation and promotes gemcitabine antitumor activity in orthotopic human pancreatic cancer xenografts in immunodeficient mice. Clin Cancer Res (2001) 1.47
Acceleration of bone-marrow recovery by pre-treatment with cyclophosphamide in patients receiving high-dose melphalan. Lancet (1978) 1.40
Association of DNA index and S-phase fraction with prognosis of nodes positive early breast cancer. Cancer Res (1987) 1.40
Measurement of MAP kinase activation by flow cytometry using phospho-specific antibodies to MEK and ERK: potential for pharmacodynamic monitoring of signal transduction inhibitors. Cytometry (2001) 1.36
Monocytes and macrophages in malignant melanoma. I. Peripheral blood macrophage precursors. Br J Cancer (1977) 1.30
The Physical State of Viral Nucleic Acid and the Sensitivity of Viruses to Ultraviolet Light. Biophys J (1965) 1.29
Molecular mechanisms for the hypoxia-dependent activation of 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR 4233). Biochem Pharmacol (1988) 1.28
Presence of a heterozygous substitution and its relationship to DT-diaphorase activity. Br J Cancer (1995) 1.28
The interaction of caffeine with ultra-violet-light-irradiated DNA. Int J Radiat Biol Relat Stud Phys Chem Med (1970) 1.27
Effects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancer. Br J Cancer (2008) 1.27
Increased sensitivity of acute myeloid leukemias to lovastatin-induced apoptosis: A potential therapeutic approach. Blood (1999) 1.24
Immunohistochemical detection of proliferating cells in vivo. J Histochem Cytochem (1987) 1.22
Equilibrative-sensitive nucleoside transporter and its role in gemcitabine sensitivity. Cancer Res (2000) 1.20
Differences in the toxicity and metabolism of the 2-nitroimidazole misonidazole (Ro-07-0582) in HeLa and Chinese hamster ovary cells. Cancer Res (1978) 1.19
A polymorphism in NAD(P)H:quinone oxidoreductase (NQO1): relationship of a homozygous mutation at position 609 of the NQO1 cDNA to NQO1 activity. Br J Cancer (1996) 1.19
An experimental and analytical study of oxygen depletion in stirred cell suspensions. Radiat Res (1980) 1.18
Effects of gemcitabine on APE/ref-1 endonuclease activity in pancreatic cancer cells, and the therapeutic potential of antisense oligonucleotides. Br J Cancer (2004) 1.17
Testing of hypoxic cell radiosensitizers in vivo. Br J Cancer Suppl (1978) 1.16
Nascent DNA synthesis in ultraviolet light-irradiated mouse L cells. Biochim Biophys Acta (1972) 1.15
Simultaneous detection of mitochondrial respiratory chain activity and reactive oxygen in digitonin-permeabilized cells using flow cytometry. Cytometry (2000) 1.14
Ultraviolet irradiation of mouse L cells: effects on DNA synthesis and progression through the cell cycle. Radiat Res (1968) 1.14
High dose melphalan and non-cryopreserved autologous bone marrow treatment of malignant melanoma and neuroblastoma. Exp Hematol (1979) 1.13
Hypoxia-inducible factor-1alpha is an intrinsic marker for hypoxia in cervical cancer xenografts. Cancer Res (2001) 1.12
Influence of cellular DNA content on disease-free survival of Stage II breast cancer patients. Cancer Res (1984) 1.11
Flow cytometric analysis of cellular DNA content as an adjunct to the diagnosis of ovarian tumours of borderline malignancy. Pathology (1984) 1.11
Treatment of advanced malignant melanoma with high-dose melphalan and autologous bone marrow transplantation. Br J Cancer (1983) 1.11
Effects of caffeine on ultraviolet-irradiated mouse L cells. Radiat Res (1969) 1.10
The influence of age on the DNA ploidy levels of breast tumours. Eur J Cancer Clin Oncol (1983) 1.09
Metastatic adeno or undifferentiated carcinoma from an unknown primary site--natural history and guidelines for identification of treatable subsets. Q J Med (1987) 1.08
Pharmacology and toxicology of sensitizers: mechanism studies. Int J Radiat Oncol Biol Phys (1984) 1.08
Contamination of mononuclear cell suspensions obtained from cancer patients by the Böyum method. Br J Cancer (1978) 1.08
A study of doxorubicin loading onto and release from sulfopropyl dextran ion-exchange microspheres. J Control Release (2001) 1.07
DT-diaphorase activity and mitomycin C sensitivity in non-transformed cell strains derived from members of a cancer-prone family. Carcinogenesis (1991) 1.05
Activity of mitomycin C for aerobic and hypoxic cells in vitro and in vivo. Cancer Res (1983) 1.05
Effects of dimethyl sulfoxide and hypoxic cell radiosensitizers on the radiation response of the KHT murine tumor in vivo. Radiat Res (1977) 1.04
Deficient activation by a human cell strain leads to mitomycin resistance under aerobic but not hypoxic conditions. Br J Cancer (1989) 1.03
The prognostic significance of proliferative activity in poor histology non-Hodgkin's lymphoma: a flow cytometry study using archival material. Eur J Cancer Clin Oncol (1987) 0.99
The metabolism and pharmacokinetics of the hypoxic cell radiosensitizer and cytotoxic agent, misonidazole, in C3H mice. Radiat Res (1981) 0.97
Prediction of long-term survival by flow cytometric analysis of cellular DNA content in patients with advanced ovarian cancer. J Clin Oncol (1988) 0.97
Measurement of intracellular pH. Methods Cell Biol (1990) 0.96
Nascent DNA synthesis in ultraviolet light-irradiated mouse, human and Chinese hamster cells. Biophys J (1974) 0.96
Tumour ploidy, response and survival in patients receiving endocrine therapy for advanced breast cancer. Br J Cancer (1985) 0.95
Receptor- and mitochondrial-mediated apoptosis in acute leukemia: a translational view. Blood (2001) 0.94
Monocytes and macrophages in malignant melanoma. III. Reduction of nitroblue tetrazolium by peripheral blood monocytes. Br J Cancer (1978) 0.94
Screening for the mutagenicity of nitro-group containing hypoxic cell radiosensitizers using Salmonella typhimurium strains TA 100 and TA98. Mutat Res (1978) 0.93
Targeting radiosensitizers to DNA by attachment of an intercalating group: nitroimidazole-linked phenanthridines. Radiat Res (1991) 0.93
Sulphydryls, ascorbate and oxygen as modifiers of the toxicity and metabolism of misonidazole in vitro. Br J Cancer (1980) 0.92
Ultraviolet-light irradiation of mouse L cells: effects on cells in the DNA synthesis phase. Radiat Res (1969) 0.91
Lovastatin induces a pronounced differentiation response in acute myeloid leukemias. Leuk Lymphoma (2000) 0.90
Evaluation of baclofen (Lioresal) for spasticity in multiple sclerosis. Postgrad Med J (1975) 0.89
Relationships between the mitochondrial permeability transition and oxidative stress during ara-C toxicity. Cancer Res (1997) 0.89
Bcl-2 targeted to the endoplasmic reticulum can inhibit apoptosis induced by Myc but not etoposide in Rat-1 fibroblasts. Oncogene (1999) 0.89
Mechanism of ultrasound enhanced porphyrin cytotoxicity. Part I: A search for free radical effects. Ultrasound Med Biol (1997) 0.88
DNA-targeted 2-nitroimidazoles: in vitro and in vivo studies. Br J Cancer (1994) 0.88
Measurement of cellular DNA content as an adjunct to diagnostic cytology in malignant effusions. Eur J Cancer Clin Oncol (1984) 0.88
5-Fluorouracil infusions and fractionated doses of radiation: studies with a murine squamous cell carcinoma. Int J Radiat Oncol Biol Phys (1987) 0.88
Modification of the cytotoxic activity of mitomycin C by oxygen and ascorbic acid in Chinese hamster ovary cells and a repair-deficient mutant. Cancer Res (1986) 0.87
Studies on the mechanism of resistance to mitomycin C and porfiromycin in a human cell strain derived from a cancer-prone individual. Biochem Pharmacol (1991) 0.87
Relationship of DNA topoisomerase II alpha and beta expression to cytotoxicity of antineoplastic agents in human acute lymphoblastic leukemia cell lines. Cancer Res (1995) 0.87
The survival of synchronized L cells after ultraviolet irradiation. Radiat Res (1966) 0.87
Effects of thymidylate synthase inhibition on thymidine kinase activity and nucleoside transporter expression. Cancer Res (1995) 0.87
Tumour regression and survival of patients with disseminated malignant melanoma treated with chemotherapy and specific active immunotherapy. Eur J Cancer (1977) 0.87
A phase I/II study of imatinib plus reinduction therapy for c-kit-positive relapsed/refractory acute myeloid leukemia: inhibition of Akt activation correlates with complete response. Leukemia (2011) 0.86
Mechanistic studies of enhanced in vitro radiosensitization and hypoxic cell cytotoxicity by targeting radiosensitizers to DNA via intercalation. Int J Radiat Oncol Biol Phys (1992) 0.86
Identification of two major reduction products of the hypoxic cell toxin 3-amino-1,2,4-benzotriazine-1,4-dioxide. Biochem Pharmacol (1986) 0.86
ICI D1694 and idoxuridine: a synergistic antitumor combination. Cancer Res (1994) 0.85
Growth delay in a murine squamous cell tumor after local radiation and concurrent infusional 5-fluorouracil treatment. Int J Radiat Oncol Biol Phys (1986) 0.85
Measurement of low levels of oxygen and their effect on respiration in cell suspensions maintained in an open system. Radiat Res (1986) 0.85
Spontaneous phenotypic and karyotypic progression in the SV40 transfected cell line SVG during prolonged passage in vitro. J Neurooncol (1990) 0.85
Preparation, toxicity and mutagenicity of 1-methyl-2-nitrosoimidazole. A toxic 2-nitroimidazole reduction product. Biochem Pharmacol (1988) 0.84
An oxidative stress-mediated death pathway in irradiated human leukemia cells mapped using multilaser flow cytometry. Radiat Res (1998) 0.84
Mechanism of the selective hypoxic cytotoxicity of 1-methyl-2-nitroimidazole. Biochem Pharmacol (1994) 0.84
Differential effects of depleting agents on cytoplasmic and nuclear non-protein sulphydryls: a fluorescence image cytometry study. Br J Cancer (1995) 0.84
Respiratory chain-generated oxidative stress following treatment of leukemic blasts with DNA-damaging agents. Exp Cell Res (2001) 0.84
p53 gene status and chemosensitivity of childhood acute lymphoblastic leukemia cells to adriamycin. Leuk Res (1999) 0.84
Effect of 1-methyl-2-nitrosoimidazole on intracellular thiols and calcium levels in Chinese hamster ovary cells. Biochem Pharmacol (1991) 0.84
Oxygen and exposure kinetics as factors influencing the cytotoxicity of porfiromycin, a mitomycin C analogue, in Chinese hamster ovary cells. Cancer Res (1988) 0.83
Microregional heterogeneity of non-protein thiols in cervical carcinomas assessed by combined use of HPLC and fluorescence image analysis. Clin Cancer Res (2000) 0.83
A toxicity study of daily dose metronidazole with pelvic irradiation. Cancer Clin Trials (1980) 0.83
Use of a high frequency ultrasound microscope to image the action of 2-nitroimidazoles in multicellular spheroids. Br J Cancer (1992) 0.83
Association between tissue hypoxia and elevated non-protein sulphydryl concentrations in human cervical carcinoma xenografts. Br J Cancer (1999) 0.82
Transferrin receptor cycling by human lymphoid cells: lack of effect from inhibition of microtubule assembly. Biochem Biophys Res Commun (1986) 0.82
Assessment of tumor cell repopulation after chemotherapy for advanced ovarian cancer: pilot study. Cytometry A (2003) 0.82
The oxygen dependence of the reduction of nitroimidazoles in a radiolytic model system. Int J Radiat Oncol Biol Phys (1984) 0.82
Measurement of intracellular pH. Methods Cell Biol (1994) 0.82
Inhibition of gamma-glutamyl transpeptidase activity decreases intracellular cysteine levels in cervical carcinoma. Cancer Chemother Pharmacol (2004) 0.82
Modulation of the equilibrative nucleoside transporter by inhibitors of DNA synthesis. Br J Cancer (1995) 0.82